Clinical Trial: Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s

U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07832084) titled 'Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s' on Sept. 15.

Brief Summary: The purpose of this research is to compare weight loss among 3 groups:

1. people who stay on a GLP-1 drug at full strength (Group 1)

2. people who have their dose tapered to every other week, meaning slowly decreasing the dose and frequency of the full prescription you are currently taking (Group 2)

3. people who go off their GLP-1 and instead take an alternative weight loss drug or combination of drugs called bupropion & naltrexone. These are not GLP-1 medications. (Group 3)

The investigators w...